Field dossier · from the corpus
Stage (stratigraphy)
0predicted collisions
Where this field is predicted to collide
No open collisions on this field in the current run.
Most cited work
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage
Current and Future Development in Lung Cancer Diagnosis